Final valorisation

From proof-of-concept to market authorization

 

Our technologies and innovations reach the market through out-licensing to our industrial partners or through the creation of our own spin-offs.

 

Also during this phase of technology transfer our combination of scientific expertise, knowledge and know-how on animal health with an entrepreneurial organisation of scientists and experienced tech-transfer professionals is an important asset for a successful collaboration with our partners.

 

We are in contact with EMA (European Medicines Agency) and national agencies who evaluate applications for market authorizations. We understand the requirements and conditions and hence are familiar with the process of developing innovations towards market authorization. Our interactions with these agencies’ Innovation Offices enable us to receive early input on the regulatory landscape related to our innovations and to take this into account as much as possible in the design of our proof-of-concept studies.

 

If a company decides to enter into a license or option agreement with us, we are open to assist during the phases of technology transfer, development, and registration. This can be done through transfer of material and assays as well as by performing efficacy and first-safety studies in our facilities and on the target species.